Inhaled corticosteroids and risk of osteoporosis in late-middle-aged subjects : a multicenter European cohort study
BACKGROUND: Inhaled corticosteroids have been widely used for the regular treatment of asthma and chronic obstructive pulmonary diseases (COPD) over the past few decades. To date, studies investigating the effects of inhaled corticosteroids (ICS) on bone in populations including asthma and COPD patients, show conflicting results. The skeletal effects of ICS remain poorly understood. We assessed the association between ICS exposure and self-reported osteoporosis diagnosis in a European cohort study.
METHODS: The analysis was carried out by using clinical and questionnaire data available for subjects participating in the ECRHS III (European Community Respiratory Health Survey) with age >55 years.
RESULTS: Among the 3004 enrolled subjects, 245 were ICS users with an exposure ≥12 months. Osteoporosis was reported by 16 subjects in the ICS group (6.5%) and by 167 in the not exposed group (6.1%). The adjusted risk of osteoporosis in ICS users (≥12 months) was not greater in exposed subjects when compared with the unexposed ones (OR=1.02, 95CI%: 0.51, 2.03). The same result was observed even when considering in the analysis a longer exposure to the ICS use (≥36.5 months, the median ICS exposure for all subjects). History of COPD, use of oral corticosteroids, Body Mass Index, smoking and physical activity did not show any evidence of an association with osteoporosis.
CONCLUSIONS: Our study did not show any significant association between long- term ICS use and self-reported diagnosis of osteoporosis in subjects aged >55 years. To explore the real effect of ICS on bone status, further studies are needed, especially in the long-term ICS exposure.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:114 |
|---|---|
| Enthalten in: |
Minerva medica - 114(2023), 1 vom: 11. Feb., Seite 15-21 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Grosso, Amelia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.02.2023 Date Revised 22.02.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.23736/S0026-4806.21.07431-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326623949 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326623949 | ||
| 003 | DE-627 | ||
| 005 | 20231225195008.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.23736/S0026-4806.21.07431-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1088.xml |
| 035 | |a (DE-627)NLM326623949 | ||
| 035 | |a (NLM)34114441 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Grosso, Amelia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Inhaled corticosteroids and risk of osteoporosis in late-middle-aged subjects |b a multicenter European cohort study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.02.2023 | ||
| 500 | |a Date Revised 22.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Inhaled corticosteroids have been widely used for the regular treatment of asthma and chronic obstructive pulmonary diseases (COPD) over the past few decades. To date, studies investigating the effects of inhaled corticosteroids (ICS) on bone in populations including asthma and COPD patients, show conflicting results. The skeletal effects of ICS remain poorly understood. We assessed the association between ICS exposure and self-reported osteoporosis diagnosis in a European cohort study | ||
| 520 | |a METHODS: The analysis was carried out by using clinical and questionnaire data available for subjects participating in the ECRHS III (European Community Respiratory Health Survey) with age >55 years | ||
| 520 | |a RESULTS: Among the 3004 enrolled subjects, 245 were ICS users with an exposure ≥12 months. Osteoporosis was reported by 16 subjects in the ICS group (6.5%) and by 167 in the not exposed group (6.1%). The adjusted risk of osteoporosis in ICS users (≥12 months) was not greater in exposed subjects when compared with the unexposed ones (OR=1.02, 95CI%: 0.51, 2.03). The same result was observed even when considering in the analysis a longer exposure to the ICS use (≥36.5 months, the median ICS exposure for all subjects). History of COPD, use of oral corticosteroids, Body Mass Index, smoking and physical activity did not show any evidence of an association with osteoporosis | ||
| 520 | |a CONCLUSIONS: Our study did not show any significant association between long- term ICS use and self-reported diagnosis of osteoporosis in subjects aged >55 years. To explore the real effect of ICS on bone status, further studies are needed, especially in the long-term ICS exposure | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 700 | 1 | |a Cerveri, Isa |e verfasserin |4 aut | |
| 700 | 1 | |a Cazzoletti, Lucia |e verfasserin |4 aut | |
| 700 | 1 | |a Zanolin, Maria E |e verfasserin |4 aut | |
| 700 | 1 | |a Mattioli, Veronica |e verfasserin |4 aut | |
| 700 | 1 | |a Piloni, Davide |e verfasserin |4 aut | |
| 700 | 1 | |a Gini, Erica |e verfasserin |4 aut | |
| 700 | 1 | |a Albicini, Federica |e verfasserin |4 aut | |
| 700 | 1 | |a Ronzoni, Vanessa |e verfasserin |4 aut | |
| 700 | 1 | |a Jarvis, Debbie |e verfasserin |4 aut | |
| 700 | 1 | |a Janson, Christer |e verfasserin |4 aut | |
| 700 | 1 | |a Corsico, Angelo G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Minerva medica |d 1945 |g 114(2023), 1 vom: 11. Feb., Seite 15-21 |w (DE-627)NLM000053686 |x 1827-1669 |7 nnns |
| 773 | 1 | 8 | |g volume:114 |g year:2023 |g number:1 |g day:11 |g month:02 |g pages:15-21 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.23736/S0026-4806.21.07431-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 114 |j 2023 |e 1 |b 11 |c 02 |h 15-21 | ||